Qingdao Vland Biotech Co (SHSE:603739) Other Financing: ¥-32 Mil (TTM As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHSE:603739 Qingdao Vland Biotech Co Ltd SHSE:603739
82 GF Score
Price ¥11.49
GF Value ¥14.52
Valuation Modestly Undervalued
! 7 Warning Signs
View Full Analysis

What is Qingdao Vland Biotech Co Other Financing?

Qingdao Vland Biotech Co SHSE:603739 -0.17% 82 Other Financing is ¥-32 Mil as of Mar. 2026. GuruFocus rates SHSE:603739 with a GF Score™ of 82/100 and a GF Value™ of ¥14.52 (Modestly Undervalued). The stock has 7 warning signs investors should review.

Qingdao Vland Biotech Co's Other Financing for the three months ended in Mar. 2026 was ¥-9 Mil.

Qingdao Vland Biotech Co's Other Financing for the trailing twelve months (TTM) ended in Mar. 2026 was ¥-32 Mil.

Qingdao Vland Biotech Co Other Financing Historical Data

* Premium members only.

The historical data trend for Qingdao Vland Biotech Co's Other Financing can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Qingdao Vland Biotech Co Other Financing Chart

Qingdao Vland Biotech Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Financing
Get a 7-Day Free Trial Premium Member Only Premium Member Only 450.79 -5.36 -3.98 -13.67 -31.40

Qingdao Vland Biotech Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Other Financing Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -8.52 -11.80 -0.67 -10.41 -9.30
SHSE:603739
82GF Score
Qingdao Vland Biotech Co Ltd SHSE:603739
Other Financing is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Qingdao Vland Biotech Co Other Financing Calculation

Other Financing represents other cash flow from financing activity that not otherwise classified, which includes:
Proceeds From Stock Option Exercised
Other Financing Charges

Other Financing for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥-32 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Other Financing →
What does a Other Financing of ¥-32 Mil mean?
Qingdao Vland Biotech Co (SHSE:603739) has a Other Financing of ¥-32 Mil as of Mar. 2026. Other Financing represents other cash flow from financing activity that not otherwise classified. View historical data for Qingdao Vland Biotech Co and its competitors.
Is Qingdao Vland Biotech Co's Other Financing too high?
Qingdao Vland Biotech Co's current Other Financing is ¥-32 Mil. Overall, Qingdao Vland Biotech Co has a GF Score™ of 82/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Qingdao Vland Biotech Co's Other Financing compare to VRTX and REGN?
Qingdao Vland Biotech Co's Other Financing of ¥-32 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Financing for a Biotechnology company?
A good Other Financing depends on the Biotechnology industry context. However, Other Financing should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Financing mean?
A high Other Financing can signal that a stock is expensive relative to its fundamentals. Other Financing represents other cash flow from financing activity that not otherwise classified. View historical data for Qingdao Vland Biotech Co and its competitors. Qingdao Vland Biotech Co's current Other Financing is ¥-32 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Qingdao Vland Biotech Co stock overvalued right now?
Based on GuruFocus' analysis, Qingdao Vland Biotech Co (SHSE:603739) is currently considered Modestly Undervalued. The stock's GF Value™ is ¥14.52, compared to a current price of ¥11.49 — trading 20.9% below its estimated fair value. The current Other Financing is ¥-32 Mil. Qingdao Vland Biotech Co's overall GF Score™ is 82/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Financing calculated?
Other Financing is calculated from a company's financial statements. For Qingdao Vland Biotech Co (SHSE:603739), the current Other Financing is ¥-32 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Qingdao Vland Biotech Co (SHSE:603739) Overvalued in 2026?

Based on GuruFocus' analysis, Qingdao Vland Biotech Co stock appears to be undervalued. The current stock price of ¥11.49 is trading 20.9% below its estimated GF Value™ of ¥14.52. GuruFocus considers Qingdao Vland Biotech Co to be Modestly Undervalued.

Key valuation signals for SHSE:603739:

  • Other Financing: ¥-32 Mil
  • GF Value™: ¥14.52 vs. price of ¥11.49 (20.9% below fair value)
  • GF Score™: 82/100 with 7 warning signs

No single metric tells the full story. See the SHSE:603739 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Qingdao Vland Biotech Co Business Description

Address No. 1318, Wangsha Road, Room 108, Enterprise Service Center, Chengyang District, Shandong, Qingdao, CHN, 266100
Qingdao Vland Biotech Co Ltd is a biotechnology company. The company is engaged in research and development of four main product categories which are enzymes, probiotics, vaccines and animal health products.
82GF Score

Get the complete analysis for SHSE:603739

Other Financing is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥11.49
Price
¥14.52
GF Value